Justice Delayed, No More – The Supreme Court’s New Deadline

Introduction: When Time Becomes Injustice The balance of justice is not hampered by any bias or discrimination, but by absolute delays. There are over 5 crore pending cases in courts all over India with litigants waiting for over decades. This judicial crisis had its turning point in the Supreme Court case of Ravindra Pratap Shahi […]

Rules on Live-streaming of Court Proceedings

Introduction The ability to watch live court hearings is included in the right to access justice, which is guaranteed by Article 21 of the Constitution. In the Mirajkar case, it was decided that “the proceedings of a Court of Justice shall be open to the public, save in extraordinary situations.” An e-Committee of the SC […]

An Analysis Of The Intellectual Property Rights Division Rules, 2021

The Tribunals Reforms Bill, 2021 had initially proposed the ideal that a select few appellate bodies be dissolved and the powers they hold were to be transferred to pre-existing judicial bodies. The Intellectual Property Appellate Board (IPAB) was one amongst the few to go through the process of being dissolved. In the landmark case of […]

Roche sues Biocon and Mylan over biosimilar version of Herceptin in India

Trastuzumab/Herceptin has been amidst several controversies off lately and this time it is regarding a biosimilar which has jointly been manufactured by Biocon and Mylan. Background Roche’s breast cancer drug Herceptin sold under the brand names HERCEPTIN, HERCLONTM and BICELTIS is a biological drug used primarily for the treatment for human epidermal growth factor receptor […]

Roche sues Biocon and Mylan over biosimilar version of Herceptin in India

Trastuzumab/Herceptin has been amidst several controversies off lately and this time it is regarding a biosimilar which has jointly been manufactured by Biocon and Mylan. Background Roche’s breast cancer drug Herceptin sold under the brand names HERCEPTIN, HERCLONTM and BICELTIS is a biological drug used primarily for the treatment for human epidermal growth factor receptor […]

Roche’s Struggle Over its Patents in India – Two suits, Two oppositions

The struggle between innovator pharmaceutical companies (mostly in the Western world) and developing world Generic companies have been lately played out in India and especially for the last 2-3 years in the form of litigations and oppositions. Here I would be discussing the specific case of Roche (a Swiss Pharma Company) showcasing its journey of […]